Achieve Life Sciences grants 180,000 stock options

Achieve Life Sciences, Inc. reported a new equity award for Chief Operations Officer Craig Donnelly.

Rhea-AI Filing Summary

Achieve Life Sciences, Inc. reported a new equity award for Chief Operations Officer Craig Donnelly. He received a stock option to buy 180,000 shares of common stock at an exercise price of $4.36 per share, dated January 28, 2026.

The option vests as to one-quarter of the total award on the first anniversary of January 28, 2026, then in substantially equal monthly installments over the following 36 months, contingent on his continued service. After this grant, Donnelly beneficially owns 180,000 stock options directly.

Insider Trade Summary

Grant/Award: 180,000 shares

Grant/Award 1 txn

Insider Donnelly Craig

Role Chief Operations Officer

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (right to buy)	180,000	$0.00	$0.00

Holdings After Transaction: Stock Option (right to buy) — 180,000 contracts (Direct)

Footnotes (1)

1. F1. The option will vest as to 1/4 of the total award on the first anniversary of January 28, 2026, and thereafter in substantially equal monthly installments over 36 months, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did ACHV report for Craig Donnelly?

Achieve Life Sciences reported a grant of stock options to Chief Operations Officer Craig Donnelly for 180,000 shares. The options were awarded at a $4.36 exercise price and represent his beneficial ownership of derivative securities following the transaction.

How many ACHV stock options were granted to the COO?

Craig Donnelly received stock options covering 180,000 shares of Achieve Life Sciences common stock. These options give him the right to buy shares at a fixed $4.36 exercise price, subject to a multi-year vesting schedule tied to continued service.

What is the exercise price of Craig Donnelly’s ACHV stock options?

The stock options granted to Craig Donnelly have an exercise price of $4.36 per share. This means he can purchase Achieve Life Sciences common stock at $4.36 once the options vest and are exercisable, assuming he remains in service through each vesting date.

When do Craig Donnelly’s ACHV stock options vest?

The option vests as to one-quarter of the total award on the first anniversary of January 28, 2026. The remaining portion vests in substantially equal monthly installments over 36 months, conditioned on Donnelly’s continued service with Achieve Life Sciences.

How many ACHV derivative securities does Craig Donnelly own after this grant?

Following this stock option grant, Craig Donnelly beneficially owns 180,000 derivative securities in the form of stock options. These options are held directly and are tied to Achieve Life Sciences common stock, subject to the stated vesting schedule and exercise terms.

Is Craig Donnelly’s ACHV stock option grant a direct or indirect holding?

Craig Donnelly’s stock option grant is reported as a direct holding. The Form 4 identifies his ownership form as “D” for direct, with no indication that the options are held through a separate entity or indirect arrangement.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/30/2026 - 04:07 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Donnelly Craig

(Last) (First) (Middle)

22722 29TH DR. SE

SUITE 100

(Street)

BOTHELL WA 98021

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ACHIEVE LIFE SCIENCES, INC. [ ACHV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Operations Officer

3. Date of Earliest Transaction (Month/Day/Year)
01/28/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$4.36	01/28/2026		A		180,000		(1)	01/28/2036	Common Stock	180,000	$0	180,000	D

Explanation of Responses:

1. The option will vest as to 1/4 of the total award on the first anniversary of January 28, 2026, and thereafter in substantially equal monthly installments over 36 months, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

	Sandra Thomson as attorney-in-fact for Craig Donnelly	01/30/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.